Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Total Assets (Quarterly) : 1.148B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.148B |
| December 31, 2025 | 1.107B |
| September 30, 2025 | 1.052B |
| June 30, 2025 | 971.92M |
| March 31, 2025 | 908.87M |
| December 31, 2024 | 854.49M |
| September 30, 2024 | 772.01M |
| June 30, 2024 | 706.36M |
| March 31, 2024 | 646.68M |
| December 31, 2023 | 471.91M |
| September 30, 2023 | 413.21M |
| June 30, 2023 | 443.90M |
| March 31, 2023 | 407.23M |
| December 31, 2022 | 376.97M |
| September 30, 2022 | 333.11M |
| June 30, 2022 | 267.31M |
| March 31, 2022 | 246.97M |
| December 31, 2021 | 237.79M |
| September 30, 2021 | 223.25M |
| June 30, 2021 | 209.13M |
| March 31, 2021 | 197.22M |
| December 31, 2020 | 192.35M |
| September 30, 2020 | 174.86M |
| June 30, 2020 | 131.41M |
| March 31, 2020 | 117.88M |
| Date | Value |
|---|---|
| December 31, 2019 | 112.38M |
| September 30, 2019 | 96.69M |
| June 30, 2019 | 78.23M |
| March 31, 2019 | 61.08M |
| December 31, 2018 | 60.45M |
| September 30, 2018 | 67.71M |
| June 30, 2018 | 74.29M |
| March 31, 2018 | 79.13M |
| December 31, 2017 | 85.39M |
| September 30, 2017 | 34.63M |
| June 30, 2017 | 35.98M |
| March 31, 2017 | 37.70M |
| December 31, 2016 | 41.71M |
| September 30, 2016 | 45.31M |
| June 30, 2016 | 48.94M |
| March 31, 2016 | 53.67M |
| December 31, 2015 | 60.10M |
| September 30, 2015 | 64.56M |
| June 30, 2015 | 68.34M |
| March 31, 2015 | 76.05M |
| December 31, 2014 | 43.91M |
| September 30, 2014 | 45.84M |
| June 30, 2014 | 45.93M |
| March 31, 2014 | 22.23M |
| December 31, 2013 | 25.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 49.39M |
| Indivior Pharmaceuticals, Inc. | 1.233B |
| Exelixis, Inc. | 2.494B |
| United Therapeutics Corp. | 7.220B |
| Krystal Biotech, Inc. | 1.501B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 134.91M |
| Shareholders Equity (Quarterly) | 1.013B |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.00% |